Topic Review
Heterogeneity Sources in Metabolic Dysfunction-Associated Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is a slowly progressing disease, beginning with isolated liver steatosis that evolves in a subset of patients to non-alcoholic steatohepatitis (NASH), liver fibrosis, cirrhosis and hepatocellular carcinoma (HCC). It was recently proposed to redefine NAFLD to metabolic dysfunction-associated fatty liver disease (MAFLD) in which other known causes of liver disease such as alcohol consumption or viral hepatitis do not need to be excluded. Revised nomenclature envisions speeding up and facilitating anti-MAFLD drug development by means of patient stratification whereby each subgroup would benefit from distinct pharmacological interventions. 
  • 589
  • 24 Jan 2022
Topic Review
Endemic Plants of Mauritius in Biomedicine
Resistance to the existing arsenal of therapeutic agents significantly impedes successful drug therapy. One approach to combat this burgeoning global crisis is to provide novel and more effective clinical agents. Terrestrial plants have long been exploited as a source of novel drug candidates. In this line, the endemic floral diversity of the Republic of Mauritius cannot be ignored. However, developing drugs from these plants is a multi-stepped, lengthy process that requires multistakeholder involvement from scientists, policymakers, and conservationists as well as the local community. 
  • 589
  • 28 Jul 2023
Topic Review
mRNA, Live-Attenuated/Chimeric and VLP-Based Vaccines
Respiratory syncytial virus (RSV) is an enveloped, negative-sense, single-stranded RNA virus causing seasonal infections in a biphasic age distribution, affecting more frequently children until the age of 2 years with a higher frequency across the age spectrum from 6 weeks to 6 months, as well as older adults due to the reduction of immunity. 
  • 589
  • 03 Nov 2023
Topic Review
Thiolated-Polymer-Based Nanoparticles
Thiomers (or thiolated polymers) have broken through as avant-garde approaches in anticancer therapy. Their distinguished reactivity and properties, closely linked to their final applications, justify the extensive research conducted on their preparation and use as smart drug-delivery systems (DDSs).
  • 587
  • 22 Jun 2021
Topic Review
4D Printing Technology
4D printing (4DP) is an evolution of 3DP where additive manufacturing printing techniques are employed. In other words, adapting 3DP processes for 4DP of shape memory polymers (SMPs) or smart materials requires minor adjustments. In order to produce the desired shape-changing materials as per estimation or for optimal application, an air circulation system may be incorporated into 3DP’s traditional fused deposition method (FDM) technology. This would cool the SMP below its Tg and, after these small alterations, previous 3DP methods such as stereolithography apparatus (SLA), digital laser writing and inkjet printing can also be employed.
  • 587
  • 05 Jan 2023
Topic Review
Titanium (IV) Oxide in Dermal Formulations
The widespread role of titanium (IV) oxide (TiO2) in many industries makes this substance of broad scientific interest. TiO2 can act as both a photoprotector and photocatalyst, and the potential for its role in both applications increases when present in nanometer-sized crystals. Its sunlight-scattering properties are used extensively in sunscreens.
  • 587
  • 12 May 2023
Topic Review
Effect of Curcumin Consumption on Inflammation/Oxidative Stress
Advanced chronic kidney disease (CKD) stages lead to exacerbated inflammation and oxidative stress. Patients with CKD in stage 5 need renal hemodialysis (HD) to remove toxins and waste products. However, this renal replacement therapy (RRT) is inefficient in controlling inflammation. Regular curcumin consumption has been shown to reduce inflammation and oxidative stress in subjects with chronic pathologies, suggesting that the daily intake of curcumin may alleviate these conditions in HD patients.
  • 587
  • 26 Jun 2023
Topic Review
Adverse Side Effects of Long-Term Lithium Therapy
Lithium remains the drug of first choice for prophylactic treatment of bipolar disorder, preventing the recurrences of manic and depressive episodes. The longitudinal experiences with lithium administration greatly exceed those with other mood stabilizers. Among the adverse side effects of lithium, renal, gastrointestinal, neurological, thyroid, metabolic, cognitive, dermatological, cardiologic, and sexual are listed. Probably, the most important negative effect of lithium, occurring mostly after 10–20 years of its administration, is interstitial nephropathy.
  • 586
  • 06 Feb 2023
Topic Review
Physalis alkekengi L. var. franchetii (Mast.) Makino
The calyxes and fruits of Physalis alkekengi L. var. franchetii (Mast.) Makino (P. alkekengi), a medicinal and edible plant, are frequently used as heat-clearing and detoxifying agents in thousands of Chinese medicine prescriptions. For thousands of years in China, they have been widely used in clinical practice to treat throat disease, hepatitis, and bacillary dysentery.
  • 585
  • 11 Feb 2022
Topic Review
Plant Isoflavones Daidzein
Isoflavones (including daidzein, the glycoside forms of daidzein, and glycitein, the methoxylated form of daidzein) are bioactive compounds that are present in significant quantities in legumes, soybeans, green beans, and mung beans.
  • 585
  • 29 Apr 2021
Topic Review
Aflatoxins in Dogs Fed
The Aflatoxins (AF) are difuranocoumarin compounds produced as secondary metabolites of fungi of the genus Aspergillus spp. following a polyketide path.
  • 583
  • 07 Feb 2021
Topic Review
The Useful Antiviral Properties of Lysozyme
Lysozyme, especially the one obtained from hen’s egg white, continues to show new pharmacological properties. Lysozyme can interact with nucleic acids and alter their function, but this effect is uncoupled from the catalytic activity that determines its antibacterial activity; it is present in intact lysozyme but is equally potent in a heat-degraded lysozyme or in a nonapeptide isolated by proteolytic digestion.
  • 583
  • 08 Feb 2024
Topic Review
Cyclodextrin Multicomponent Complexes: Pharmaceutical Applications
Cyclodextrins (CD) are a family of macromolecules obtained by enzymatic degradation of starch. Their structure resembles a truncated cone, with a somewhat lipophilic central cavity and an external hydrophilic surface.  Due to these characteristics the pharmaceutical applications are mostly related to the ability of CDs to form inclusion complexes, formed by interactions between guest (drug) and host (CD) molecules, and they have the ability to modulate several properties positively affecting the performances and therapeutic profiles of drugs. Besides, a drug–CD complex with the addition of an auxiliary substance, that are called multicomponent or ternary complex, can have a synergic effect, allowing the use of low concentrations of the host compounds, thereby optimizing the cost, toxicity and formulation volume in the final product. Also, these additives such as amino acids, organic acids and bases, and water-soluble polymers interacting with CDs can modulate in vitro and in vivo drug dissolution, thereby modifying the drug’s pharmacokinetic profile.
  • 581
  • 30 Aug 2021
Topic Review
Symmetrical Compounds in Insulin-Sensitizing Treatments for Type 2 Diabetes
Type 2 diabetes is a complex disease that involves damage to multiple signaling pathways. Through various pathways, chronic high blood glucose generates or aggravates insulin resistance. The drugs most widely used to decrease insulin resistance without producing hypoglycemia are biguanides (e.g., metformin) and thiazolidinediones (TZDs, such as pioglitazone). Symmetrical molecules have been a focus of research due to their unique structural characteristics, including stability and internal balance. Some advantages and disadvantages of utilizing symmetrical and asymmetrical thiazolidinediones as insulin sensitizers (or even antioxidant molecules) are mentioned.
  • 581
  • 27 Jun 2022
Topic Review
IPSCs and organoids in ASD
Autism spectrum disorder (ASD) encompasses a broad range of complex polygenic and multifactorial neurodevelopmental diseases affecting social interaction, communication, interests, and behavior. The major limit to ASD research remains a lack of relevant models which can faithfully re-capitulate key features of the pathology. Recent advances in induced pluripotent stem cells (iPSCs), reprogrammed from somatic cells of patients, have provided a promising cellular tool for disease modelling and development of novel drug treatments. Moreover, iPSCs can be differentiated and organized into 3D organoids, providing a model which mimics the complexity of the brain’s architecture. 
  • 581
  • 15 Jun 2021
Topic Review
Copper Chelators and cDDP Resistance
The platinum (Pt)-containing antitumor drugs including cisplatin (cis-diamminedichloroplatinum II, cDDP), carboplatin, and oxaliplatin, have been the mainstay of cancer chemotherapy. These drugs are effective in treating many human malignancies. The major cell-killing target of Pt drugs is DNA. Recent findings underscored the important roles of Pt drug transport system in cancer therapy. It was demonstrated that by reducing cellular Cu bioavailable levels by Cu chelators, hCtr1 is transcriptionally upregulated by transcription factor Sp1, which binds the promoters of Sp1 and hCtr1. In contrast, elevated Cu poisons Sp1, resulting in suppression of hCtr1 and Sp1, constituting the Cu-Sp1-hCtr1 mutually regulatory loop.
  • 580
  • 21 Jun 2021
Topic Review
Practical Considerations for Next-Generation Adjuvant Development and Translation
Throughout the last two decades, there has been increasing focus on the discovery and translation of new immune-stimulating agents. These compounds are often collectively referred to as adjuvants due to their precedent of use in vaccine development. There has been an expansion in the application of adjuvants in oncology and other areas as the understanding and definition of adjuvants continue to grow. Adjuvants stimulate key cell types in the innate immune system and can influence the scale and class of immune response directed towards a given antigen or antigens.
  • 580
  • 07 Jul 2023
Topic Review
Pharmacokinetics/Pharmacogenetics in Atypical LAI Antipsychotics
Over the last two decades, pharmacogenetics and pharmacokinetics have been increasingly used in clinical practice in Psychiatry due to the high variability regarding response and side effects of antipsychotic drugs. Specifically, long-acting injectable (LAI) antipsychotics have different pharmacokinetic profile than oral formulations due to their sustained release characteristics. In addition, most of these drugs are metabolized by CYP2D6, whose interindividual genetic variability results in different metabolizer status and, consequently, into different plasma concentrations of the drugs. In this context, there is consistent evidence which supports the use of therapeutic drug monitoring (TDM) along with pharmacogenetic tests to improve safety and efficacy of antipsychotic pharmacotherapy. 
  • 579
  • 07 Jul 2021
Topic Review
Plant-Derived and Bacterial Extracellular Vesicles as Oral Therapeutics
Extracellular vesicles (EVs) from various sources, including edible plants, milk, bacteria and mammalian cells, have emerged as a platform for miRNA and drug delivery that seem to induce the expected immune effects locally and in distant tissues after oral administration. Such a possibility greatly expands the clinical applicability of EVs. Much focuses are on the EVs from edible plants and bacteria. Growing evidence has suggested possible therapeutic applications for nanoparticles derived from edible plants, especially when administered orally to induce immunomodulation. And it was emphasized that the important immunomodulatory impact of microbiota may also be mediated by microbial EVs, formerly called outer membrane vesicles (OMVs).
  • 579
  • 15 Jul 2022
Topic Review
Hepatic CYP2E1 in Causal Toxicity and Treatment Options
Cytochrome P450 2E1 (CYP2E1), one of the major metabolizing enzymes in humans, is mainly expressed in the liver. Alcohol and several therapeutic drugs, including acetaminophen, are metabolized by CYP2E1 into toxic compounds. At low levels, these compounds are not detrimental, but higher sustained levels of these compounds can lead to life-long problems such as cytotoxicity, organ damage, and cancer. Furthermore, CYP2E1 can facilitate or enhance the effects of alcohol-drug and drug-drug interactions.
  • 579
  • 13 Sep 2022
  • Page
  • of
  • 53
ScholarVision Creations